CTLA-4 overexpression in CD19+/CD5+ cells correlates with the level of cell cycle regulators and disease progression in B-CLL patients.
Kosmaczewska
A
A
Ciszak
L
L
Suwalska
K
K
Wolowiec
D
D
Frydecka
I
I
D015703:Antigens, CD / Q000097:blood; D018941:Antigens, CD19 / Q000097:blood*; D000943:Antigens, Differentiation / Q000097:blood* / Q000235:genetics; D001402:B-Lymphocytes / Q000276:immunology* / Q000473:pathology; D018956:CD5 Antigens / Q000097:blood; D060908:CTLA-4 Antigen; D002453:Cell Cycle / Q000276:immunology*; D018450:Disease Progression; D005091:Exons; D005260:Female; D005838:Genotype; D006801:Humans; D007141:Immunoglobulin Fc Fragments / Q000097:blood / Q000235:genetics; D015448:Leukemia, B-Cell / Q000097:blood / Q000276:immunology*; D008297:Male; D011401:Promoter Regions, Genetic; D012016:Reference Values; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D015703:Antigens, CD; D018941:Antigens, CD19; D000943:Antigens, Differentiation; D018956:CD5 Antigens; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D007141:Immunoglobulin Fc Fragments